Patients with scarce ß-cell function, long-duration of T2D and severe diseases (elevated HbA1c or use of multiple antidiabetic drugs and, particularly, insulin therapy) have lower chance of remission. This evidence concerns the gene INS and type 2 diabetes mellitus.